HEADER APOPTOSIS 05-FEB-24 8VXM TITLE HUMAN BCL-2/BCL-XL CHIMERA FUSED TO MBP IN COMPLEX WITH INHIBITOR TITLE 2 S55746 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN FUSED TO COMPND 3 APOPTOSIS REGULATOR BCL-2/BCL-XL CHIMERA; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: BCL2-L-1,APOPTOSIS REGULATOR BCL-X; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: FOR THE ALIGNMENT, MBP (UNP P0AEX9, 27-392) SPANS COMPND 8 RESIDUES 19-384 (W/ SURFACE ENTROPY REDUCTION MUTATIONS AT 100, 101, COMPND 9 190, 191, AND 257) AND IS FUSED TO A BCL-2/BCL-XL CHIMERA VIA A COMPND 10 LINKER SEQUENCE (AARAAA) SPANNING 385-390. BCL-2 (UNP P10415, 10-207) COMPND 11 HAS THE UNSTRUCTURED LOOP SPANNING 35-91 DELETED AND REPLACED WITH COMPND 12 BCL-XL (UNP Q07817, 29-44) FOR RESIDUES 35-50 OF THE BCL-2/BCL-XL COMPND 13 CHIMERA, SO BCL-2 SPANS 391-415 AND 432-547, WHILE BCL-XL SPANS 416- COMPND 14 431. FOR THE 3D MODEL, MBP (-362-3), LINKER (4-9), BCL-2 (10-34 AND COMPND 15 92-207), AND BCL-XL (35-50). THR88, GLU89, SER90, AND GLU91 OF THE COMPND 16 FINAL MODEL CORRESPOND TO RESIDUES 47-50 (BCL-XL) OF THE LOOP COMPND 17 REPLACEMENT (35-50). SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 83333, 9606; SOURCE 5 STRAIN: K-12; SOURCE 6 GENE: MALE, B4034, JW3994, BCL2, BCL2L1, BCL2L, BCLX; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-24B(+) KEYWDS APOPTOSIS, BCL-2, MBP FUSION, BCL-XL CHIMERA, S55746, COMPLEX, KEYWDS 2 PROTEIN-PROTEIN INTERFACE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.BAIRD,M.HOLLIDAY REVDAT 1 02-OCT-24 8VXM 0 JRNL AUTH Y.SUN,D.HOUDE,R.E.IACOB,J.BAIRD,R.V.SWIFT,M.HOLLIDAY,X.SHI, JRNL AUTH 2 S.SIDOLI,M.BRENOWITZ JRNL TITL COMPLEMENTARY BACKBONE AND SIDE-CHAIN ANALYSIS OF JRNL TITL 2 DRUG-PROTEIN INTERACTIONS: COMBINING HYDROGEN/DEUTERIUM JRNL TITL 3 EXCHANGE AND PROTEIN OXIDATIVE FOOTPRINTING TO DISCRIMINATE JRNL TITL 4 THE BINDING OF SMALL MOLECULE THERAPEUTICS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.45 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 33673 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 67.4500 - 4.8100 1.00 2958 155 0.1811 0.1831 REMARK 3 2 4.8100 - 3.8200 1.00 2818 158 0.1725 0.2126 REMARK 3 3 3.8200 - 3.3300 1.00 2795 143 0.2123 0.2514 REMARK 3 4 3.3300 - 3.0300 1.00 2784 133 0.2618 0.2608 REMARK 3 5 3.0300 - 2.8100 1.00 2714 164 0.2811 0.2921 REMARK 3 6 2.8100 - 2.6500 0.74 2053 104 0.2631 0.2768 REMARK 3 7 2.6500 - 2.5100 0.99 2717 152 0.2539 0.3083 REMARK 3 8 2.5100 - 2.4000 1.00 2712 142 0.2596 0.3253 REMARK 3 9 2.4000 - 2.3100 0.99 2718 140 0.2751 0.3121 REMARK 3 10 2.3100 - 2.2300 0.83 2300 104 0.2698 0.3593 REMARK 3 11 2.2300 - 2.1600 0.99 2705 146 0.2936 0.3406 REMARK 3 12 2.1600 - 2.1000 0.99 2705 153 0.3079 0.3530 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.322 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.082 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.02 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4219 REMARK 3 ANGLE : 0.405 5727 REMARK 3 CHIRALITY : 0.037 603 REMARK 3 PLANARITY : 0.004 755 REMARK 3 DIHEDRAL : 21.097 1563 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -8.4716 7.5024 -16.3265 REMARK 3 T TENSOR REMARK 3 T11: 0.5287 T22: 0.2748 REMARK 3 T33: 0.5474 T12: -0.0392 REMARK 3 T13: -0.0071 T23: -0.0177 REMARK 3 L TENSOR REMARK 3 L11: 0.5178 L22: 1.9517 REMARK 3 L33: 1.2110 L12: -0.1757 REMARK 3 L13: 0.0218 L23: -0.7462 REMARK 3 S TENSOR REMARK 3 S11: -0.0163 S12: 0.0449 S13: -0.0013 REMARK 3 S21: -0.2537 S22: -0.0478 S23: 0.0138 REMARK 3 S31: 0.1508 S32: -0.0091 S33: 0.0514 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8VXM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-24. REMARK 100 THE DEPOSITION ID IS D_1000281259. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC 1.1.7 REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35939 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.035 REMARK 200 RESOLUTION RANGE LOW (A) : 67.455 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.84400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS (PH 8.5), 25% PEG 3350, REMARK 280 200 MM LITHIUM SULFATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.40000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.45500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.37000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.45500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.40000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.37000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -380 REMARK 465 HIS A -379 REMARK 465 HIS A -378 REMARK 465 HIS A -377 REMARK 465 HIS A -376 REMARK 465 HIS A -375 REMARK 465 HIS A -374 REMARK 465 HIS A -373 REMARK 465 HIS A -372 REMARK 465 HIS A -371 REMARK 465 HIS A -370 REMARK 465 GLU A -369 REMARK 465 ASN A -368 REMARK 465 LEU A -367 REMARK 465 TYR A -366 REMARK 465 PHE A -365 REMARK 465 GLN A -364 REMARK 465 GLY A -363 REMARK 465 GLY A 33 REMARK 465 ASP A 34 REMARK 465 ASP A 76 REMARK 465 VAL A 77 REMARK 465 GLU A 78 REMARK 465 GLU A 79 REMARK 465 ASN A 80 REMARK 465 ARG A 81 REMARK 465 THR A 82 REMARK 465 GLU A 83 REMARK 465 ALA A 84 REMARK 465 PRO A 85 REMARK 465 GLU A 86 REMARK 465 GLY A 87 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A-195 -73.18 -73.92 REMARK 500 ASP A-154 -160.89 -108.89 REMARK 500 TYR A -80 -51.35 -126.14 REMARK 500 ASN A -31 43.54 -91.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8VWZ RELATED DB: PDB REMARK 900 G101V MUTANT BOUND TO S55746 REMARK 900 RELATED ID: 8VWX RELATED DB: PDB REMARK 900 G101V MUTANT, APO REMARK 900 RELATED ID: 8VXN RELATED DB: PDB REMARK 900 WT, APO DBREF 8VXM A -362 3 UNP P0AEX9 MALE_ECOLI 27 392 DBREF 8VXM A 10 34 UNP P10415 BCL2_HUMAN 10 34 DBREF 8VXM A 76 91 UNP Q07817 B2CL1_HUMAN 29 44 DBREF 8VXM A 92 207 UNP P10415 BCL2_HUMAN 92 207 SEQADV 8VXM MET A -380 UNP P0AEX9 INITIATING METHIONINE SEQADV 8VXM HIS A -379 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -378 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -377 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -376 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -375 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -374 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -373 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -372 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -371 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM HIS A -370 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM GLU A -369 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM ASN A -368 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM LEU A -367 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM TYR A -366 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM PHE A -365 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM GLN A -364 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM GLY A -363 UNP P0AEX9 EXPRESSION TAG SEQADV 8VXM ALA A -281 UNP P0AEX9 ASP 108 ENGINEERED MUTATION SEQADV 8VXM ALA A -280 UNP P0AEX9 LYS 109 ENGINEERED MUTATION SEQADV 8VXM ALA A -191 UNP P0AEX9 GLU 198 ENGINEERED MUTATION SEQADV 8VXM ALA A -190 UNP P0AEX9 ASN 199 ENGINEERED MUTATION SEQADV 8VXM ALA A -124 UNP P0AEX9 LYS 265 ENGINEERED MUTATION SEQADV 8VXM ALA A 4 UNP P0AEX9 LINKER SEQADV 8VXM ALA A 5 UNP P0AEX9 LINKER SEQADV 8VXM ARG A 6 UNP P0AEX9 LINKER SEQADV 8VXM ALA A 7 UNP P0AEX9 LINKER SEQADV 8VXM ALA A 8 UNP P0AEX9 LINKER SEQADV 8VXM ALA A 9 UNP P0AEX9 LINKER SEQRES 1 A 547 MET HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS GLU ASN SEQRES 2 A 547 LEU TYR PHE GLN GLY LYS ILE GLU GLU GLY LYS LEU VAL SEQRES 3 A 547 ILE TRP ILE ASN GLY ASP LYS GLY TYR ASN GLY LEU ALA SEQRES 4 A 547 GLU VAL GLY LYS LYS PHE GLU LYS ASP THR GLY ILE LYS SEQRES 5 A 547 VAL THR VAL GLU HIS PRO ASP LYS LEU GLU GLU LYS PHE SEQRES 6 A 547 PRO GLN VAL ALA ALA THR GLY ASP GLY PRO ASP ILE ILE SEQRES 7 A 547 PHE TRP ALA HIS ASP ARG PHE GLY GLY TYR ALA GLN SER SEQRES 8 A 547 GLY LEU LEU ALA GLU ILE THR PRO ALA ALA ALA PHE GLN SEQRES 9 A 547 ASP LYS LEU TYR PRO PHE THR TRP ASP ALA VAL ARG TYR SEQRES 10 A 547 ASN GLY LYS LEU ILE ALA TYR PRO ILE ALA VAL GLU ALA SEQRES 11 A 547 LEU SER LEU ILE TYR ASN LYS ASP LEU LEU PRO ASN PRO SEQRES 12 A 547 PRO LYS THR TRP GLU GLU ILE PRO ALA LEU ASP LYS GLU SEQRES 13 A 547 LEU LYS ALA LYS GLY LYS SER ALA LEU MET PHE ASN LEU SEQRES 14 A 547 GLN GLU PRO TYR PHE THR TRP PRO LEU ILE ALA ALA ASP SEQRES 15 A 547 GLY GLY TYR ALA PHE LYS TYR ALA ALA GLY LYS TYR ASP SEQRES 16 A 547 ILE LYS ASP VAL GLY VAL ASP ASN ALA GLY ALA LYS ALA SEQRES 17 A 547 GLY LEU THR PHE LEU VAL ASP LEU ILE LYS ASN LYS HIS SEQRES 18 A 547 MET ASN ALA ASP THR ASP TYR SER ILE ALA GLU ALA ALA SEQRES 19 A 547 PHE ASN LYS GLY GLU THR ALA MET THR ILE ASN GLY PRO SEQRES 20 A 547 TRP ALA TRP SER ASN ILE ASP THR SER ALA VAL ASN TYR SEQRES 21 A 547 GLY VAL THR VAL LEU PRO THR PHE LYS GLY GLN PRO SER SEQRES 22 A 547 LYS PRO PHE VAL GLY VAL LEU SER ALA GLY ILE ASN ALA SEQRES 23 A 547 ALA SER PRO ASN LYS GLU LEU ALA LYS GLU PHE LEU GLU SEQRES 24 A 547 ASN TYR LEU LEU THR ASP GLU GLY LEU GLU ALA VAL ASN SEQRES 25 A 547 LYS ASP LYS PRO LEU GLY ALA VAL ALA LEU LYS SER TYR SEQRES 26 A 547 GLU GLU GLU LEU ALA LYS ASP PRO ARG ILE ALA ALA THR SEQRES 27 A 547 MET GLU ASN ALA GLN LYS GLY GLU ILE MET PRO ASN ILE SEQRES 28 A 547 PRO GLN MET SER ALA PHE TRP TYR ALA VAL ARG THR ALA SEQRES 29 A 547 VAL ILE ASN ALA ALA SER GLY ARG GLN THR VAL ASP GLU SEQRES 30 A 547 ALA LEU LYS ASP ALA GLN THR ALA ALA ARG ALA ALA ALA SEQRES 31 A 547 ASP ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR LYS SEQRES 32 A 547 LEU SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP ASP SEQRES 33 A 547 VAL GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SEQRES 34 A 547 SER GLU VAL VAL HIS LEU THR LEU ARG GLN ALA GLY ASP SEQRES 35 A 547 ASP PHE SER ARG ARG TYR ARG ARG ASP PHE ALA GLU MET SEQRES 36 A 547 SER SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY SEQRES 37 A 547 ARG PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY SEQRES 38 A 547 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY SEQRES 39 A 547 GLY VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER SEQRES 40 A 547 PRO LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR SEQRES 41 A 547 LEU ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY SEQRES 42 A 547 GLY TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET SEQRES 43 A 547 ARG HET F3Q A 301 53 HET PEG A 302 7 HETNAM F3Q ~{N}-(4-HYDROXYPHENYL)-3-[6-[[(3~{S})-3-(MORPHOLIN-4- HETNAM 2 F3Q YLMETHYL)-3,4-DIHYDRO-1~{H}-ISOQUINOLIN-2- HETNAM 3 F3Q YL]CARBONYL]-1,3-BENZODIOXOL-5-YL]-~{N}-PHENYL-5,6,7, HETNAM 4 F3Q 8-TETRAHYDROINDOLIZINE-1-CARBOXAMIDE HETNAM PEG DI(HYDROXYETHYL)ETHER FORMUL 2 F3Q C43 H42 N4 O6 FORMUL 3 PEG C4 H10 O3 FORMUL 4 HOH *68(H2 O) HELIX 1 AA1 GLY A -347 GLY A -331 1 17 HELIX 2 AA2 LYS A -321 ALA A -311 1 11 HELIX 3 AA3 ARG A -297 SER A -290 1 8 HELIX 4 AA4 ALA A -281 ASP A -276 1 6 HELIX 5 AA5 TYR A -273 VAL A -266 1 8 HELIX 6 AA6 GLU A -232 ALA A -222 1 11 HELIX 7 AA7 GLU A -210 ALA A -201 1 10 HELIX 8 AA8 ASN A -178 ASN A -162 1 17 HELIX 9 AA9 ASP A -154 ASN A -145 1 10 HELIX 10 AB1 GLY A -135 TRP A -133 5 3 HELIX 11 AB2 ALA A -132 SER A -125 1 8 HELIX 12 AB3 ASN A -91 TYR A -80 1 12 HELIX 13 AB4 THR A -77 LYS A -66 1 12 HELIX 14 AB5 LEU A -59 ALA A -51 1 9 HELIX 15 AB6 ASP A -49 GLY A -36 1 14 HELIX 16 AB7 GLN A -28 SER A -11 1 18 HELIX 17 AB8 THR A -7 ARG A 26 1 34 HELIX 18 AB9 GLU A 91 TYR A 108 1 18 HELIX 19 AC1 TYR A 108 LEU A 119 1 12 HELIX 20 AC2 THR A 125 ARG A 139 1 15 HELIX 21 AC3 ASN A 143 ARG A 164 1 22 HELIX 22 AC4 SER A 167 HIS A 184 1 18 HELIX 23 AC5 HIS A 184 ASN A 192 1 9 HELIX 24 AC6 GLY A 193 GLY A 203 1 11 HELIX 25 AC7 PRO A 204 MET A 206 5 3 SHEET 1 AA1 6 LYS A-329 GLU A-325 0 SHEET 2 AA1 6 LYS A-357 TRP A-353 1 N ILE A-354 O GLU A-325 SHEET 3 AA1 6 ILE A-304 ALA A-300 1 O ILE A-304 N TRP A-353 SHEET 4 AA1 6 PHE A-105 ILE A -97 -1 O GLY A -98 N ILE A-303 SHEET 5 AA1 6 TYR A-257 GLU A-252 -1 N ILE A-255 O LEU A-101 SHEET 6 AA1 6 ALA A -62 VAL A -61 -1 O ALA A -62 N VAL A-253 SHEET 1 AA2 5 LYS A-329 GLU A-325 0 SHEET 2 AA2 5 LYS A-357 TRP A-353 1 N ILE A-354 O GLU A-325 SHEET 3 AA2 5 ILE A-304 ALA A-300 1 O ILE A-304 N TRP A-353 SHEET 4 AA2 5 PHE A-105 ILE A -97 -1 O GLY A -98 N ILE A-303 SHEET 5 AA2 5 GLU A -35 ILE A -34 1 O GLU A -35 N VAL A-104 SHEET 1 AA3 2 ARG A-265 TYR A-264 0 SHEET 2 AA3 2 LYS A-261 LEU A-260 -1 O LYS A-261 N TYR A-264 SHEET 1 AA4 4 SER A-218 LEU A-216 0 SHEET 2 AA4 4 THR A-141 ASN A-136 1 O ALA A-140 N SER A-218 SHEET 3 AA4 4 SER A-249 ASN A-245 -1 N ASN A-245 O ALA A-140 SHEET 4 AA4 4 TYR A-121 THR A-118 -1 O GLY A-120 N TYR A-246 SHEET 1 AA5 2 TYR A-196 ALA A-191 0 SHEET 2 AA5 2 LYS A-188 GLY A-181 -1 O ASP A-186 N LYS A-193 CRYST1 48.800 88.740 134.910 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020492 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011269 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007412 0.00000